Corporate Banner
Satellite Banner
Technology Networks Header
Friday, December 19, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Smart Cancer Diagnostics from Austria Impresses in Italy
Tuesday, November 01, 2011
tecnet supports successful sales partnership of Anagnostics.

Microsaic Systems Showcases the Microsaic 3500 MiD®
Tuesday, October 18, 2011
Microsaic showcases Microsaic 3500 MiD® at the 3rd Symposium on Continuous Flow Reactor Technology.

mPhase Technologies Granted Access to Technical Facilities at Argonne National Labs
Monday, October 17, 2011
mPhase to explore approaches for optimizing the design of the MEMS Smart silicon membrane.

Dolomite Launches Mitos P-Pump Basic
Monday, October 10, 2011
Providing a simple, reliable and cost effective solution for pulseless liquid flow.

Randox Toxicology Biochip Array Technology Helps the Criminal Justice System in South Africa
Monday, October 10, 2011
Immunoassay technology permits accurate analysis of biological specimens for drugs of abuse at high speeds.

Fluidigm Technology Used to Validate New Risk Loci for Graves Disease
Friday, October 07, 2011
Rujin Hospital in Shanghai uses company's IFCs to validate two new susceptibility loci.

Illumina Introduces Low-Cost Bovine BeadChip for Genotyping of Dairy Cattle
Tuesday, October 04, 2011
Optimized content and price to enable wider use of genomic selection.

Labsmith Introduces uProcess™ Suite of Automation Products
Tuesday, October 04, 2011
Designed to simplify construction and control of microfluidic systems.

LabSmith Automated Valves Speed Construction of Micro/Nano-fluidic Experimental Setups
Saturday, October 01, 2011
Company has added automated valves to its uProcess family of hardware and software products.

<< 9 10 11 12 13 14 15 >>
Showing Results 111 - 120 of 1049
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn